1. Home
  2. ENVB vs AMBO Comparison

ENVB vs AMBO Comparison

Compare ENVB & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enveric Biosciences Inc.

ENVB

Enveric Biosciences Inc.

HOLD

Current Price

$1.39

Market Cap

8.1M

Sector

Health Care

ML Signal

HOLD

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

N/A

Current Price

$2.08

Market Cap

6.5M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
ENVB
AMBO
Founded
1994
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
8.1M
6.5M
IPO Year
2000
2010

Fundamental Metrics

Financial Performance
Metric
ENVB
AMBO
Price
$1.39
$2.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
126.3K
19.3K
Earning Date
05-14-2026
08-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
337.04
EPS
N/A
0.00
Revenue
$39,914,675.00
$9,469,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$412.24
Revenue Growth
N/A
0.82
52 Week Low
$0.56
$1.47
52 Week High
$13.25
$6.75

Technical Indicators

Market Signals
Indicator
ENVB
AMBO
Relative Strength Index (RSI) 44.85 39.72
Support Level N/A $1.74
Resistance Level $1.54 $2.64
Average True Range (ATR) 0.12 0.16
MACD -0.01 0.01
Stochastic Oscillator 32.61 40.92

Price Performance

Historical Comparison
ENVB
AMBO

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

Share on Social Networks: